ArticleThe Journal of infectious diseases2025
Impact of Population Immunity and Public Health Measures on the Transmission of Omicron Subvariants BA.2 and BA.5 in Hong Kong.
Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and population-level vaccine administration have significantly shifted the population immunity. In Hong Kong, these shifts, coupled with the emergence of Omicron BA.5 with a strong ability of immune evasion, necessitate a deeper understanding of how population immunity and public health and social measures (PHSMs) have shaped the epidemic dynamics across age groups within the population.
methodsWe developed an age-structured, multistrain model and estimated key parameters including transmissibility for the emerging BA.5, the effects of PHSMs on transmission, and contributions of natural infection and vaccination to age-specific immunity against infection of each subvariant over time.
resultsWe found that reactive PHSMs implemented in February 2022 decreased the time-varying effective reproductive number without the effect of immunity (RtWI) by 67% (95% credible interval [CrI], 52%-78%). However, subsequent relaxation of control measures since April 2022, alongside the enhanced transmissibility of BA.5, drove RtWI back to 3.4 (95% CrI, 2.8-4.1) by late May. Prior to the fifth wave, only 15% of the Hong Kong population had immunity and protection against BA.2 infection. Population immunity against BA.2 infection then increased significantly to 55% within 2 months given 47% cumulative infections and >30% vaccination uptake. Subsequently, with the emergence of BA.5, population immunity against BA.5 infection was 15% lower than that against BA.2 during the end of May.
conclusionsOur findings underscore the dynamic interplay between population immunity, PHSMs, and variant transmissibility and highlight the potential risks posed by immune-evasive variants in the context of waning immunity and control relaxation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.